Skip to main content
. 2013 Feb 3;36(3):139–145. doi: 10.1002/clc.22089

Table 3.

Unadjusted and Multivariate Adjusted HRs for 10‐Month Clinical Endpoints

HR (95% CI)
Unadjusted Multivariate Adjusted
All‐cause death (n = 25)
 Quartiles
 1 1.00 1.00
 2 2.22 (0.55–8.86) 1.51 (0.33–6.83)
 3 2.16 (0.52–9.06) 1.86 (0.44–7.87)
 4 3.94 (1.10–14.13)a 3.97 (1.09–14.41)a
MI (n = 31)
 Quartiles
 1 1.00 1.00
 2 0.75 (0.29–1.97) 0.67 (0.24–1.85)
 3 0.86 (0.33–2.27) 0.74 (0.27–2.04)
 4 0.75 (0.29–1.98) 0.71 (0.27–1.88)
Primary composite (n = 117)
 Quartiles
 1 1.00 1.00
 2 1.20 (0.73–1.98) 1.10 (0.66–1.85)
 3 1.12 (0.68–1.90) 0.99 (0.57–1.70)
 4 1.11 (0.66–1.84) 0.98 (0.57–1.66)
CHF (n = 27)
 Quartiles
 1 1.00 1.00
 2 1.29 (0.43–3.85) 1.34 (0.44–4.08)
 3 1.27 (0.41–3.95) 0.76 (0.22–2.58)
 4 1.58 (0.56–4.44) 1.73 (0.60–4.97)

Abbreviations: BNP, B‐type natriuretic peptide; CHF, congestive heart failure; CI, confidence interval; CrCl, creatinine clearance; HR, hazard ratio; MI, myocardial infarction. Multivariate adjustment of risk included the following variables: age, diabetes, prior MI, prior CHF, ST deviation (>1 mm), CrCl, BNP (>80 pg/mL), current smoking, and Killip class (I vs II–IV).

The interval increased HR for the fourth quartile of catalytic iron was statistically significant for both the unadjusted (P = 0.035) and multivariate adjusted models (P = 0.036).